Invizi IP Pty Ltd – Trademark Portfolio

Entity Type: 99

Invizi IP Pty Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include INVIZI. The owner is based in Sydney.

Level 7, 88 Phillip Street

C/- Sw Accountants & Advisors Pty Ltd

Sydney NSW2000 , AU

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NUNDIES
NUNDIES
Pending 2024
INVIZI
INVIZI
Registered 2024

Trademark Classifications

Invizi IP Pty Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Invizi IP Pty Ltd have?

Invizi IP Pty Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Invizi IP Pty Ltd file in?

Invizi IP Pty Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Invizi IP Pty Ltd's most well-known trademarks?

Invizi IP Pty Ltd's registered trademark portfolio includes well-known marks such as INVIZI. These are among 1 currently registered trademark in the portfolio.

What is Invizi IP Pty Ltd's trademark registration success rate?

Invizi IP Pty Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.